Cardiff Oncology, Inc. (TROV) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	16.3	11.9	131.0	10.2	11.5	8.2	13.9	67.5
Short-term investments	88.9	128.9					24.0
Accounts receivable, net	0.8	0.5	0.3	0.2	0.2	0.1	0.1	0.1
Other current assets	5.2	4.8	2.1	1.0	1.1	1.2	1.0	0.8
Total current assets	111.3	146.1	133.4	11.4	12.8	9.5	39.0	68.4
Property, plant, and equipment, net	1.3	0.4	0.6	0.9	1.3	2.4	3.8	2.7
Long-term investments	5.0	33.3
Other fixed assets	1.4	0.2	0.4	0.2	0.1	0.4	1.2	0.4
Total assets	116.2	149.5	134.7	13.1	14.2	12.3	44.0	71.4

Accounts payable	2.0	1.4	1.4	0.7	0.7	0.8	1.1	1.0
Accrued expenses	5.2	4.5	3.9	3.3	1.8	1.5	4.0	1.9
Current portion of long-term debt	0.0	0.0	0.0	0.0	0.0	1.3	2.4	5.2
Current portion of long-term debt						1.3	2.4	5.2
Other current liabilities	0.7	0.6	0.9	0.9	0.5	0.3	0.3	0.0
Total current liabilities	7.8	6.6	6.1	4.8	2.9	3.9	7.8	8.2
Long-term debt							14.2	11.2
Other liabilities	2.0	2.6	0.5	1.0	1.2	1.8	2.2	3.3
Total liabilities	9.8	9.1	6.6	5.8	4.1	5.8	24.2	22.7

Shareholders' equity [+]	106.3	140.4	128.2	7.3	10.1	6.5	19.8	48.7
Paid-in capital	404.8	400.5	361.8	217.2	202.3	179.5	167.9	157.6
Retained earnings	-298.1	-259.8	-231.5	-208.9	-192.2	-173.0	-148.1	-108.9
Tangible shareholders' equity	106.3	140.4	128.2	7.3	10.1	6.5	19.8	48.7